BSE filing, NSE: SABOOBR. Summary written from the filing by ALFA Finder's alert engine.
Arigato Universe Ltd: key numbers
- Share price
- ₹32.35
- Market cap
- ₹19.72 Cr
- Revenue (annual)
- ₹28.60 Cr
- Net profit (annual)
- ₹2.27 Cr
- P/E (TTM)
- 6.9×Sector 51.5×
- Promoter holding
- 65.24%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Arigato Universe Ltd
All →Arigato Universe Other Announcement
Arigato Universe Ltd submitted its quarterly shareholding pattern under Regulation 31(1)(b) of SEBI LODR for the period ending September 30, 2026.
Arigato Universe Annual General Meeting
Arigato Universe Limited held its 47th Annual General Meeting on September 29, 2026, to adopt financial statements and approve various director and auditor resolutions.
Arigato Universe Annual General Meeting
Arigato Universe issued a corrigendum to its AGM notice, including updated annexures detailing the proposed allottees and investment amounts for its preferential issue of equity shares.
- Value
- ₹5.50 Cr
Arigato Universe Annual Report
Arigato Universe Limited has submitted its Annual Report for the financial year 2025-26. It includes the notice for the 47th Annual General Meeting.
Arigato Universe Annual General Meeting
Arigato Universe Limited scheduled its 47th Annual General Meeting for September 29, 2026. The meeting agenda includes approval for a proposed preferential equity share issue.
Arigato Universe Capital Structure Change
Arigato Universe Limited approved a preferential issue of 1.5 crore equity shares at ₹16 each, raising ₹24 Crore for working capital and debt repayment.
- Value
- ₹24.00 Cr
Other fund raise announcements
All →Rite Zone Chemcon India Fund Raise of ₹6.58 Cr
Rite Zone Chemcon India announced a preferential issue of 27,69,730 equity shares to 11 investors at Rs.24 each, raising about Rs.6.58 Crore. The approval awaits a shareholder vote on 23 November 2026.
- Value
- ₹6.58 Cr
Sudarshan Pharma Industries Fund Raise of ₹72 Cr
Sudarshan Pharma's board approved up to Rs. 72 Crore of preferential convertible warrants for promoters Hemal and Sachin Mehta. Shareholder approval will be sought at an EGM.
- Value
- ₹72.00 Cr
Flywings Simulator Training Centre Fund Raise of ₹68.2 Cr
Flywings Simulator's board approved Rs. 68.20 Crore fully convertible warrants on a preferential basis. Promoter Rupal Mandavia is allotted Rs. 25 Crore, subject to shareholder approval.
- Value
- ₹68.20 Cr
Kanel Industries Fund Raise of ₹16.99 Cr
Kanel Industries' board approved a rights issue of 42.52 lakh equity shares at Rs.39.95 each. The issue aggregates about Rs.16.99 Crore, with record date 13 November 2026.
- Value
- ₹16.99 Cr
- Execution
- Rights issue opens 23 November 2026 and closes 30 November 2026
Sudarshan Pharma Industries Fund Raise
Board approved issuing up to 72 Crore warrants to promoters on a preferential basis. Pricing per Reg 164 is pending, with no fixed rupee value stated.
GAIL (India) Fund Raise
GAIL Board approved in principle the IPO of subsidiary GAIL Gas Limited on Indian exchanges. GAIL will dilute its GGL equity up to 25%.